Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

14.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 19.50
  • 52 Week Low: 8.92
  • Currency: UK Pounds
  • Shares Issued: 927.98m
  • Volume: 601,540
  • Market Cap: £134.56m
  • Beta: 0.49

SCLP Overview

Scancell Holdings is in the pharma and biotech sector and is currently trading at 14.50p per share. In the last year Scancell Holdings's share price has ranged from 8.92p to 19.50p and brokers are currently rating this stock as 'buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a -881.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a 82.4
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SCLP Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Apr-20 n/a (6.77) (1.18)p n/a n/a n/a n/a 0.0%
30-Apr-21 n/a (16.81) (2.28)p n/a n/a n/a n/a 0.0%
30-Apr-22 n/a (6.27) (0.56)p n/a n/a n/a n/a 0.0%
30-Apr-23 5.27 (14.30) (1.50)p n/a n/a n/a n/a 0.0%
30-Apr-24 n/a (9.12) (0.68)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SCLP Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Apr-25 1.63 (14.39) (1.39)p n/a n/a n/a n/a 0.0%
30-Apr-26 n/a (14.36) (1.53)p n/a n/a n/a n/a 0.0%
30-Apr-27 n/a (20.95) (2.39)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

SCLP Company Announcements

Positive data from Phase 2 SCOPE trial with SCIB1 18-Nov-2024 07:00 RNS
Result of Annual General Meeting 25-Oct-2024 15:26 RNS
Holding(s) in Company 24-Oct-2024 07:00 RNS

SCLP ShareCast News

Scancell shares jump on new antibody agreement w... 12-Jun-2024 ShareCast
Scancell appoints healthcare finance veteran as ... 29-Aug-2023 ShareCast
Scancell to present positive recent findings at ... 02-Jun-2023 ShareCast

Latest SCLP Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

SCLP Market Data

Currency UK Pounds
Share Price 14.50p
Change Today -0.50p
% Change -3.33 %
52 Week High 19.50
52 Week Low 8.92
Volume 601,540
Shares Issued 927.98m
Market Cap £134.56m
Beta 0.49

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.11% below the market average10.11% below the market average10.11% below the market average10.11% below the market average10.11% below the market average
12% below the sector average12% below the sector average12% below the sector average12% below the sector average12% below the sector average
Price Trend
50.24% above the market average50.24% above the market average50.24% above the market average50.24% above the market average50.24% above the market average
79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:29 100 @ 14.11p
16:24 46 @ 14.00p
16:23 50,285 @ 14.31p
15:24 30,000 @ 14.50p
15:23 50,000 @ 14.50p

SCLP Key Personnel

CFO Sath Nirmalananthan
CEO Phil L'Huillier

Top of Page